Synthorx

Synthorx

Biotechnology, N Torrey Pnes Rd, La Jolla, , 92037, California, 11099, United States, 11-50 Employees

synthorx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is SYNTHORX

Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorxs proprietary, first-of-its-kind Expanded G...

Read More

map
  • 11099 N Torrey Pnes Rd, La Jolla, California, 92037, United States Headquarters: 11099 N Torrey Pnes Rd, La Jolla, California, 92037, United States
  • 2014 Date Founded: 2014
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SYNTHORX

Synthorx Org Chart and Mapping

Employees

Helene Pham

Senior Research Associate, Pharmacology

Wendie Konold

Sr Manager, Human Resources

Kristine Gall

Senior Research Associate

Amber Le

Senior Research Associate, Downstream

Neyssa Marina

Executive Medical Director

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Synthorx

Answer: Synthorx's headquarters are located at N Torrey Pnes Rd, La Jolla, , 92037, California, 11099, United States

Answer: Synthorx's phone number is 85********

Answer: Synthorx's official website is https://synthorx.com

Answer: Synthorx's revenue is $25 Million to $50 Million

Answer: Synthorx's SIC: 2834

Answer: Synthorx's NAICS: 325412

Answer: Synthorx has 11-50 employees

Answer: Synthorx is in Biotechnology

Answer: Synthorx contact info: Phone number: 85******** Website: https://synthorx.com

Answer: Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorxs proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The companys lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company was founded based on important discoveries in Dr. Floyd Romesbergs lab at The Scripps Research Institute. Synthorx is headquartered in La Jolla, California.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access